Entera Bio Ltd. Ordinary Shares (ENTX)
Stock · NASDAQ · Health Care
$3.03as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$1.19
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Entera Bio Ltd. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- ENTXEntera Bio Ltd. Ordinary Shares$3.03▼ 1.62%Market cap $145.90MP/E —
- CRBUCaribou Biosciences Inc. Common Stock$1.62▼ 2.41%Market cap $148.77MP/E —$1.38$3.54
- HUMAHumacyte Inc. Common Stock$0.6538▼ 5.66%Market cap $153.04MP/E —$0.5261$2.55
- LENZLENZ Therapeutics Inc. Common Stock$5.12▲ 6.34%Market cap $156.62MP/E —$4.54$50.4
- TNYATenaya Therapeutics Inc. Common Stock$0.691▼ 0.58%Market cap $158.19MP/E —$0.532$2.35
- ENGNenGene Therapeutics Inc. Common Stock$1.83▼ 4.19%Market cap $118.57MP/E —$1.4$12.25
- VYGRVoyager Therapeutics Inc. Common Stock$3.54▲ 2.17%Market cap $181.26MP/E —$2.94$5.55
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ENTX Entera Bio Ltd. Ordinary Shares | $145.90M | — | $3.03 | ▼ 1.62% | |
| CRBU Caribou Biosciences Inc. Common Stock | $148.77M | — | $1.62 | ▼ 2.41% | $1.38$3.54 |
| HUMA Humacyte Inc. Common Stock | $153.04M | — | $0.6538 | ▼ 5.66% | $0.5261$2.55 |
| LENZ LENZ Therapeutics Inc. Common Stock | $156.62M | — | $5.12 | ▲ 6.34% | $4.54$50.4 |
| TNYA Tenaya Therapeutics Inc. Common Stock | $158.19M | — | $0.691 | ▼ 0.58% | $0.532$2.35 |
| ENGN enGene Therapeutics Inc. Common Stock | $118.57M | — | $1.83 | ▼ 4.19% | $1.4$12.25 |
| VYGR Voyager Therapeutics Inc. Common Stock | $181.26M | — | $3.54 | ▲ 2.17% | $2.94$5.55 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.